Loading insider details...
Beta
Latest Form 4 (Oct 8, 2026): Exercise/Conversion of 26,338 IDYA shares, $113.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 8, 2026 | IDEAYA Biosciences, Inc. (IDYA) | Exercise/Conversion | 26,338 | $113.5K |
| Mar 13, 2026 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 20,000 | n/a |
| Feb 3, 2026 | IDEAYA Biosciences, Inc. (IDYA) | Grant/Award | 600,000 | n/a |
| Mar 14, 2025 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 15,700 | n/a |
| Feb 28, 2025 | IDEAYA Biosciences, Inc. (IDYA) | Grant/Award | 600,000 | n/a |
| Feb 19, 2025 | IDEAYA Biosciences, Inc. (IDYA) | Exercise/Conversion | 12,808 | $250.0K |
| May 16, 2024 | IDEAYA Biosciences, Inc. (IDYA) | Exercise/Conversion | 56,711 | $244.4K |
| Mar 8, 2024 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 15,700 | n/a |
| Mar 4, 2024 | IDEAYA Biosciences, Inc. (IDYA) | Grant/Award | 480,000 | n/a |
| Feb 12, 2024 | IDEAYA Biosciences, Inc. (IDYA) | Exercise/Conversion | 75,815 | $326.8K |